LongevityNext
Argue for layered, organ-specific, trajectory-based biomarkers instead of one clean consumer-facing number. The piece keeps the focus on evidence, commercial logic, and what would make the claim testable.
Evaluate heart-rate variability, sleep, gait, activity, recovery, arrhythmia detection, and the limits of consumer-device data as aging biomarkers. The piece keeps the focus on evidence, commercial logic, and…
Argue that organ-specific risk may be more clinically useful than one whole-body biological-age score. The piece keeps the focus on evidence, commercial logic, and what would make the…
The biomarker field in longevity now has a familiar problem: it is producing more interesting measurements than medicine yet knows quite what to do with. Epigenetic clocks can…
Few ideas in longevity science have spread faster than the promise of the aging clock. The sales pitch is simple enough to fit on a landing page: run…